Humana Inc.
HUMHealthcareNASDAQHealthcare Plans
Scan Results
Daily timeframeHumana Inc. provides medical and specialty insurance products in the United States. Valued at $48.02B, HUM is a large-cap name in its sector. It operates in two segments, Insurance and CenterWell.
Market Cap
$48.02B
Beta
0.72
P/E (TTM)
41.32
P/E (Fwd)
24.95
EPS (TTM)
$9.68
EPS (Fwd)
$16.03
ROE
6.3%
ROA
3.6%
Cash
$21.97B
Total Debt
$14.37B
Free CF
$1.43B
52W Change
81.5%
Annual Financials
Cash vs Debt
Humana Inc. holds $21.97B in cash against $14.37B in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $1.43B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 6.3% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.6% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $83.06B (2021) to $129.66B (2025), reflecting a 56% increase over the period.
As with any equity investment, HUM carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Humana Inc. and its sector.